Investors love shortcuts, and valuation is no exception. Open almost any stock pitch and you’ll see a forward P/E, a price-to-sales comp set, or an EV/EBITDA median slapped on next year’s numbers to justify a price target. Multiples are quick, simple, and socially acceptable. But they are also one of the most common sources of error in equity analysis – especially when applied to growth companies whose economic value sits years (or even decades) in the future.
At its foundation, valuation is about estimating the present value of a business’s future cash flows. A discounted cash flow (DCF) forces you to model those flows explicitly – revenues, margins, reinvestment, terminal economics, and risk – instead of compressing all of it into a single ratio applied to one year of earnings. That difference, says investor Gregory Blotnick, matters more than most investors acknowledge.
Why multiples persist – even when they’re wrong
The persistence of multiples is not an accident:
1) Cognitive comfort. Multiples feel “clean.” You don’t need to wrestle with discount rates, terminal growth assumptions, or capital intensity – you just pick a number.
2) Social reinforcement. Markets, X/Twitter, and sell-side notes live on brevity. “Stock trades at 50× earnings – overpriced” travels farther than a 12-page DCF.
3) Institutional incentives. Sell-side analysts covering 40 tickers don’t have time for detailed models. Buy-side portfolio managers skimming 200 names want fast heuristics, not uncertainty ranges.
Multiples survive because they are easy to produce, easy to defend, and easy to explain. But ease is a terrible proxy for accuracy.
Multiples are not “wrong” – they are incomplete
A multiple is just a DCF in disguise. A price/earnings ratio embeds beliefs about growth longevity, required returns, reinvestment, and terminal value. For mature and steady businesses – utilities, staples, slow-changing industrials – the shorthand often works because the future resembles the past.
But apply that same tool to companies with long-duration cash flows and the flaws are obvious, says Gregory Blotnick. Consider a pharmaceutical developer: five years of losses during trials, followed by a decade of blockbuster economics after approval. A year-2 or year-3 EPS multiple tells you nothing about that value arc. It punishes the early years and ignores the payoff years entirely. A “high” multiple in that context is not evidence of froth – it is often evidence of a long-dated cash flow stream.
This is where investors get into trouble. When you reduce a multi-year curve to one year of earnings, you systematically bias against growth companies and toward businesses with front-loaded profitability.
The four big blind spots of multiples-only valuation
- Short-term horizons. FY1/FY2 anchoring forgets the cash flows that actually matter in R&D-heavy or intangible-heavy businesses.
- No business model context. A 50× P/E in a utility is absurd. A 50× P/E in a software company with 90% retention and 30% reinvestment returns may be conservative.
- Accounting distortion. Earnings don’t equal cash. Depreciation schedules, stock comp rules, or revenue deferrals warp ratios. DCF focuses on cash, not GAAP artifacts.
- Terminal value invisibility. In many growth names, 60–80% of intrinsic value sits beyond year 5 – multiples literally erase that part of the curve.
Biases make the problem worse
Most investors don’t just use multiples – they use them with embedded cognitive errors:
- Anchoring: Locking onto a peer median or “30× cap” without testing assumptions.
- Availability: Trusting the nearest datapoint (next year’s EPS) over the relevant one (years 6-15).
- Herding: Treating valuation ceilings like commandments (“Nothing above 25×”) simply because others do.
- Overconfidence: Declaring a stock “absurd” without ever expressing the assumptions that would justify or refute that claim.
DCF breaks that cycle, says Blotnick, because it forces every assumption into the open and requires you to be explicit about growth, reinvestment, risk, and decay.
But DCF is not a magic wand
DCF has its own failure modes – usually caused by precision theatre rather than conceptual flaws:
- Too-rosy long-term growth
- Discount rates that never update with risk
- Terminal values that assume perfection
- Single-point estimates instead of scenarios
- Ignoring reinvestment needs while praising margin expansion
Used carelessly, DCF is just a spreadsheet with better fonts. Used rigorously, it is the only method that actually aligns valuation with how businesses generate value over time.
Where the edge lives
Mispricing is born where convenience substitutes for thinking. If the market is anchored on near-term multiples and you are the one analyst modeling years 6-15 with discipline, you own the edge. The harder the company is to value – long-cycle, intangible-led, binary-outcome, or reinvestment-heavy – the greater the advantage for those who abandon shortcuts.
The bottom line
Equities are worth the present value of all future cash flows – not just next year’s earnings. Multiples compress long arcs into one snapshot, reinforcing biases and masking the true economics of growth. DCF is not perfect, but it is honest: it forces clarity where shortcuts produce illusion.
In markets that reward speed and soundbites, the discipline of depth is not optional – it is the source of advantage. To learn more, visit Gregory Blotnick’s homepage.
